N A Sheikh

Summary

Affiliation: Dendreon Corporation
Country: USA

Publications

  1. doi request reprint CD54 is a surrogate marker of antigen presenting cell activation
    N A Sheikh
    Dendreon Corporation, 3005 1st Avenue, Seattle, WA 98121, USA
    Cancer Immunol Immunother 57:1381-90. 2008
  2. pmc Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
    Nadeem A Sheikh
    Dendreon Corporation, Seattle, WA 98102 3703, USA
    Cancer Immunol Immunother 62:137-47. 2013

Detail Information

Publications2

  1. doi request reprint CD54 is a surrogate marker of antigen presenting cell activation
    N A Sheikh
    Dendreon Corporation, 3005 1st Avenue, Seattle, WA 98121, USA
    Cancer Immunol Immunother 57:1381-90. 2008
    ..Thus these data support the use of CD54 upregulation as a surrogate for assessing human APC activation and validates its utility as a potency measure of sipuleucel-T...
  2. pmc Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
    Nadeem A Sheikh
    Dendreon Corporation, Seattle, WA 98102 3703, USA
    Cancer Immunol Immunother 62:137-47. 2013
    ..Analysis of data from three phase 3 trials was performed to immunologically characterize this therapy during the course of the three doses, and to relate the immunological responses to overall survival (OS)...